Drug Survival on First Biologic Therapy Among Late‐Onset Rheumatoid Arthritis Patients Compared to Early‐Onset Patients: A Population‐Based Cohort Study
Late-onset RA patients were treated with biologics to a lesser extent than early-onset patients, but no differences were observed in drug survival times at the first bDMARD between the two groups.
Authors
- Fadi Hassan (ORCID: https://orcid.org/0000-0002-9648-1130)
- Helana Jeries (ORCID: https://orcid.org/0000-0001-8624-6332)
- Avivit Golan‐Cohen (ORCID: https://orcid.org/0000-0003-2406-6402)
- Ilan Green (ORCID: https://orcid.org/0000-0002-9435-7152)
- Mohammad E. Naffaa (ORCID: https://orcid.org/0000-0001-9777-2864)
- Basem Hijazi
- Eugene Merzon
- Rula Daood
Institutions
- Bar-Ilan University (IL)
- Tel Aviv University (IL)
- Western Galilee Hospital (IL)
- Academic College of Tel Aviv-Yafo (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- Musculoskeletal Care
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1002/msc.1928
- Citations
- 3
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.41